233 related articles for article (PubMed ID: 18499002)
1. Efficacy of brimonidine tartrate 0.2% ophthalmic solution in reducing halos after laser in situ keratomileusis.
Lee JH; You YS; Choe CM; Lee ES
J Cataract Refract Surg; 2008 Jun; 34(6):963-7. PubMed ID: 18499002
[TBL] [Abstract][Full Text] [Related]
2. Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery.
Edwards JD; Burka JM; Bower KS; Stutzman RD; Sediq DA; Rabin JC
J Cataract Refract Surg; 2008 Sep; 34(9):1538-41. PubMed ID: 18721716
[TBL] [Abstract][Full Text] [Related]
3. Miotic effect of brimonidine tartrate 0.15% ophthalmic solution in normal eyes.
Thordsen JE; Bower KS; Warren BB; Stutzman R
J Cataract Refract Surg; 2004 Aug; 30(8):1702-6. PubMed ID: 15313293
[TBL] [Abstract][Full Text] [Related]
4. Effect of brimonidine tartrate 0.2% ophthalmic solution on pupil size.
Kesler A; Shemesh G; Rothkoff L; Lazar M
J Cataract Refract Surg; 2004 Aug; 30(8):1707-10. PubMed ID: 15313294
[TBL] [Abstract][Full Text] [Related]
5. Effect of brimonidine tartrate ophthalmic solution 0.2% on pupil size in normal eyes under different luminance conditions.
McDonald JE; El-Moatassem Kotb AM; Decker BB
J Cataract Refract Surg; 2001 Apr; 27(4):560-4. PubMed ID: 11311624
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of night vision disturbances after refractive surgery Results of a randomized clinical trial.
Randazzo A; Nizzola F; Rossetti L; Orzalesi N; Vinciguerra P
J Cataract Refract Surg; 2005 Sep; 31(9):1764-72. PubMed ID: 16246781
[TBL] [Abstract][Full Text] [Related]
7. Brimonidine versus dapiprazole: Influence on pupil size at various illumination levels.
Marx-Gross S; Krummenauer F; Dick HB; Pfeiffer N
J Cataract Refract Surg; 2005 Jul; 31(7):1372-6. PubMed ID: 16105609
[TBL] [Abstract][Full Text] [Related]
8. Aceclidine, brimonidine tartrate, and dapiprazole: comparison of miotic effect and tolerability under different lighting conditions.
Canovetti A; Nardi M; Figus M; Fogagnolo P; Benelli U
J Cataract Refract Surg; 2009 Jan; 35(1):42-6. PubMed ID: 19101423
[TBL] [Abstract][Full Text] [Related]
9. Use of brimonidine before LASIK with femtosecond laser-created flaps for the correction of myopia: a contralateral eye study.
Rodríguez-Galietero A; Martínez JV; Del Buey A; Bescós JA
J Refract Surg; 2010 Jan; 26(1):28-32. PubMed ID: 20199009
[TBL] [Abstract][Full Text] [Related]
10. Pupil size and night vision disturbances after LASIK for myopia.
Helgesen A; Hjortdal J; Ehlers N
Acta Ophthalmol Scand; 2004 Aug; 82(4):454-60. PubMed ID: 15291941
[TBL] [Abstract][Full Text] [Related]
11. Night vision disturbances after successful LASIK surgery.
Villa C; Gutiérrez R; Jiménez JR; González-Méijome JM
Br J Ophthalmol; 2007 Aug; 91(8):1031-7. PubMed ID: 17314153
[TBL] [Abstract][Full Text] [Related]
12. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
Yuen NS; Cheung P; Hui SP
Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
[TBL] [Abstract][Full Text] [Related]
13. Pupil response to tropicamide following laser in situ keratomileusis.
Chung HS; Feder RS
J Cataract Refract Surg; 2005 Mar; 31(3):553-6. PubMed ID: 15811744
[TBL] [Abstract][Full Text] [Related]
14. The effect of daily use of brimonidine tartrate on the dark-adapted pupil diameter.
Brown SM; Khanani AM; McCartney DL
Am J Ophthalmol; 2004 Jul; 138(1):149-51. PubMed ID: 15234301
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of higher-order aberrations after conventional laser in situ keratomileusis and laser epithelial keratomileusis for myopia using the technolas 217z laser platform.
Kirwan C; O'Keefe M
Am J Ophthalmol; 2009 Jan; 147(1):77-83. PubMed ID: 18775529
[TBL] [Abstract][Full Text] [Related]
16. Effect of brimonidine tartrate 0.15% on scotopic pupil: controlled trial.
Gerente VM; Biondi AC; Barbosa CP; Lottenberg CL; Paranhos A
J Ocul Pharmacol Ther; 2007 Oct; 23(5):476-80. PubMed ID: 17900228
[TBL] [Abstract][Full Text] [Related]
17. Effect of brimonidine tartrate 0.10% ophthalmic solution on pupil diameter.
Shemesh G; Moisseiev E; Lazar M; Kesler A
J Cataract Refract Surg; 2011 Mar; 37(3):486-9. PubMed ID: 21333872
[TBL] [Abstract][Full Text] [Related]
18. Early flap dislocation with perioperative brimonidine use in laser in situ keratomileusis.
Nowroozzadeh MH
J Cataract Refract Surg; 2010 Feb; 36(2):368. PubMed ID: 20152647
[No Abstract] [Full Text] [Related]
19. Comparison of optical quality metrics to predict subjective quality of vision after laser in situ keratomileusis.
Bühren J; Pesudovs K; Martin T; Strenger A; Yoon G; Kohnen T
J Cataract Refract Surg; 2009 May; 35(5):846-55. PubMed ID: 19393883
[TBL] [Abstract][Full Text] [Related]
20. Pupillometry study of brimonidine tartrate 0.2% and apraclonidine 0.5%.
Besada E; Reed K; Najman P; Shechtman D; Hardigan P
J Clin Pharmacol; 2011 Dec; 51(12):1690-5. PubMed ID: 21406599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
